Avidity Biosciences, Inc.Avidity Biosciences, Inc.Avidity Biosciences, Inc.

Avidity Biosciences, Inc.

No trades
See on Supercharts
Market capitalization
‪1.91 B‬USD
−2.90USD
‪−212.22 M‬USD
‪9.56 M‬USD
‪71.35 M‬
Beta (1Y)
2.27

About Avidity Biosciences, Inc.

CEO
Sarah Boyce
Headquarters
San Diego
Employees (FY)
253
Founded
2012
ISIN
US05370A1088
FIGI
BBG00FQ7LXW1
Avidity Biosciences, Inc. engages in the development of a new class of oligonucleotide-based therapies called Antibody Oligonucleotide Conjugates (AOC). It utilizes its AOC platform to design, engineer, and develop therapeutics that combine the tissue selectivity of monoclonal antibodies and the precision of oligonucleotide-based therapies in order to access previously undruggable tissue and cell types and more effectively target underlying genetic drivers of diseases. The company was founded by Troy E. Wilson, Kent Hawryluk, Mark E. Davis, and Francis Patrick McCormick on November 13, 2012 and is headquartered in San Diego, CA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of RNA is 23.91 USD — it hasn't changed in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Avidity Biosciences, Inc. stocks are traded under the ticker RNA.
Avidity Biosciences, Inc. is going to release the next earnings report on May 7, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for Avidity Biosciences, Inc. has a max estimate of 71.00 USD and a min estimate of 18.00 USD.
RNA earnings for the last quarter are −0.71 USD whereas the estimation was −0.76 USD which accounts for 6.17% surprise. Estimated earnings for the next quarter are −0.66 USD. See more details about Avidity Biosciences, Inc. earnings.
Avidity Biosciences, Inc. revenue for the last quarter amounts to ‪2.82 M‬ USD despite the estimated figure of ‪2.21 M‬ USD. In the next quarter revenue is expected to reach ‪12.21 M‬ USD.
Yes, you can track Avidity Biosciences, Inc. financials in yearly and quarterly reports right on TradingView.
Like other stocks, RNA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Avidity Biosciences, Inc. stock right from TradingView charts — choose your broker and connect to your account.
RNA reached its all-time high on Sep 15, 2020 with the price of 37.46 USD, and its all-time low was 4.83 USD and was reached on Oct 31, 2023.
See other stocks reaching their highest and lowest prices.
As of Apr 17, 2024, the company has 253.00 employees. See our rating of the largest employees — is Avidity Biosciences, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Avidity Biosciences, Inc. EBITDA is ‪−231.34 M‬ USD, and current EBITDA margin is ‪−2.44 K‬%. See more stats in Avidity Biosciences, Inc. financial statements.